Ruggero La Rosa

Kongens Lyngby, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Immune protection and persistence in Pseudomonas aeruginosa infections by pyruvate cross-feeding.

Immune protection and persistence in Pseudomonas aeruginosa infections by pyruvate cross-feeding.

Journal: Nature communications
Published: December 04, 2025

Carbapenem-resistance oprD mutations reshape Pseudomonas aeruginosa host-pathogen interactions during infection.

Carbapenem-resistance oprD mutations reshape Pseudomonas aeruginosa host-pathogen interactions during infection.

Journal: Nature communications
Published: October 24, 2025

Rethinking antimicrobial resistance diagnostics: beyond standardized susceptibility testing.

Rethinking antimicrobial resistance diagnostics: beyond standardized susceptibility testing.

Journal: Trends in microbiology
Published: October 23, 2025

Cell-type-independent infection dynamics of clinical Pseudomonas aeruginosa isolates in human airway epithelial models.

Cell-type-independent infection dynamics of clinical Pseudomonas aeruginosa isolates in human airway epithelial models.

Journal: Cell reports
Published: August 19, 2025

Pseudomonas aeruginosa: persistence beyond antibiotic resistance.

Pseudomonas aeruginosa: persistence beyond antibiotic resistance.

Journal: Trends in microbiology
Published: March 19, 2025

Ciprofloxacin resistance rapidly declines in nfxB defective clinical strains of Pseudomonas aeruginosa.

Ciprofloxacin resistance rapidly declines in nfxB defective clinical strains of Pseudomonas aeruginosa.

Journal: Nature communications
Published: September 11, 2024

Macrolide resistance through uL4 and uL22 ribosomal mutations in Pseudomonas aeruginosa.

Macrolide resistance through uL4 and uL22 ribosomal mutations in Pseudomonas aeruginosa.

Journal: Nature communications
Published: April 11, 2024

Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Journal: PLoS biology
Published: January 17, 2024

Adaptive Evolution of Pseudomonas aeruginosa in Human Airways Shows Phenotypic Convergence Despite Diverse Patterns of Genomic Changes.

Adaptive Evolution of Pseudomonas aeruginosa in Human Airways Shows Phenotypic Convergence Despite Diverse Patterns of Genomic Changes.

Journal: Molecular biology and evolution
Published: August 16, 2023

Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance: author's response.

Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance: author's response.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: September 05, 2022

Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance.

Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 14, 2022

Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution.

Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution.

Journal: Antibiotics (Basel, Switzerland)
Published: February 24, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026